Creative Planning’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298K Buy
71,464
+31,049
+77% +$131K ﹤0.01% 3431
2025
Q4
$111K Sell
40,415
-1,366
-3% -$3.9K ﹤0.01% 3694
2025
Q3
$143K Sell
41,781
-196
-0.5% -$715 ﹤0.01% 3590
2025
Q2
$144K Buy
41,977
+1,747
+4% +$4.61K ﹤0.01% 3344
2025
Q1
$85.7K Sell
40,230
-30
-0.1% -$90 ﹤0.01% 3274
2024
Q4
$128K Sell
40,260
-915
-2% -$7.47K ﹤0.01% 3101
2024
Q3
$550K Buy
41,175
+23,655
+135% +$315K ﹤0.01% 2012
2024
Q2
$175K Sell
17,520
-830
-5% -$12K ﹤0.01% 2715
2024
Q1
$218K Buy
18,350
+4,500
+32% +$38.4K ﹤0.01% 2508
2023
Q4
$55.7K Buy
13,850
+900
+7% +$2.53K ﹤0.01% 2637
2023
Q3
$35.4K Sell
12,950
-500
-4% -$2.33K ﹤0.01% 2523
2023
Q2
$89.8K Buy
13,450
+500
+4% +$3.04K ﹤0.01% 2363
2023
Q1
$82.6K Hold
12,950
﹤0.01% 2282
2022
Q4
$32K Hold
12,950
﹤0.01% 2282
2022
Q3
$30K Hold
12,950
﹤0.01% 2158
2022
Q2
$40K Hold
12,950
﹤0.01% 2080
2022
Q1
$47K Buy
12,950
+1,500
+13% +$5.47K ﹤0.01% 2066
2021
Q4
$44K Hold
11,450
﹤0.01% 2005
2021
Q3
$72K Hold
11,450
﹤0.01% 1975
2021
Q2
$91K Sell
11,450
-10
-0.1% -$88 ﹤0.01% 1883
2021
Q1
$125K Buy
11,460
+1,381
+14% +$20.9K ﹤0.01% 2202
2020
Q4
$45K Hold
10,079
﹤0.01% 2115
2020
Q3
$59K Buy
10,079
+7,879
+358% +$51.3K ﹤0.01% 1890
2020
Q2
$12K Hold
2,200
﹤0.01% 1864
2020
Q1
$12K Buy
+2,200
New +$16.6K ﹤0.01% 1754
2015
Q4
Sell
-4,000
Closed -$56K 4418
2015
Q3
$56K Sell
4,000
-598
-13% -$8.63K ﹤0.01% 1958
2015
Q2
$68K Buy
4,598
+4,250
+1,221% +$68.9K ﹤0.01% 1009
2015
Q1
$5K Buy
+348
New +$5.17K ﹤0.01% 3511

Other funds holding CATX